These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7572394)

  • 41. Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1.
    Briggs CJ; Ott DE; Coren LV; Oroszlan S; Tözsér J
    Arch Virol; 1999; 144(11):2151-60. PubMed ID: 10603169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strain-specific differences in the effects of cyclosporin A and FK506 on the survival and regeneration of axotomized retinal ganglion cells in adult rats.
    Cui Q; Hodgetts SI; Hu Y; Luo JM; Harvey AR
    Neuroscience; 2007 May; 146(3):986-99. PubMed ID: 17408862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of T cell cAMP formation by cyclosporin A and FK506.
    Ockenfels HM; Wagner SN; Oeljeklaus P; Schneck B; Nussbaum G; Jakobs KH; Goos M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):513-6. PubMed ID: 8740144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitory effect of the immunosuppressant FK506 on apoptotic cell death induced by HIV-1 gp120.
    Sekigawa I; Koshino K; Hishikawa T; Kaneko H; Takasaki Y; Hashimoto H; Hirose S; Inagaki Y; Yamamoto N
    J Clin Immunol; 1995 Nov; 15(6):312-7. PubMed ID: 8576317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Augmentation of T-cell apoptosis by immunosuppressive agents.
    Takahashi K; Reynolds M; Ogawa N; Longo DL; Burdick J
    Clin Transplant; 2004; 18 Suppl 12():72-5. PubMed ID: 15217412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients.
    Capecchi PL; Rechichi S; Lazzerini PE; Collini A; Guideri F; Ruggieri G; Carmellini M; Laghi-Pasini F
    Transpl Int; 2005 Mar; 18(3):289-95. PubMed ID: 15730488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of cyclosporin A, FK 506, and mycalamide A on the activation of murine CD4+ T cells by the murine B7 antigen.
    Galvin F; Freeman GJ; Razi-Wolf Z; Benacerraf B; Nadler L; Reiser H
    Eur J Immunol; 1993 Jan; 23(1):283-6. PubMed ID: 7678228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclosporin A and FK506 mediate differential effects on T cell activation in vivo.
    Bishop DK; Li W
    J Immunol; 1992 Feb; 148(4):1049-54. PubMed ID: 1371128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of FK506 on the interleukin 15-driven proliferation and apoptosis of anti-CD3-activated umbilical cord blood T cells.
    Lin SJ; Yan DC; Kuo ML; Cheng PJ; Hsiao SS; Tsai TL
    Ann Allergy Asthma Immunol; 2005 Dec; 95(6):586-92. PubMed ID: 16400900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FK506 and cyclosporin A inhibit granulocyte/macrophage colony-stimulating factor production by mononuclear cells in asthma.
    Sano T; Nakamura Y; Matsunaga Y; Takahashi T; Azuma M; Okano Y; Shimizu E; Ogushi F; Sone S; Ogura T
    Eur Respir J; 1995 Sep; 8(9):1473-8. PubMed ID: 8575571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclosporin A and FK506 inhibit activation-induced cell death in the murine WEHI-231 B cell line.
    Genestier L; Dearden-Badet MT; Bonnefoy-Berard N; Lizard G; Revillard JP
    Cell Immunol; 1994 May; 155(2):283-91. PubMed ID: 7514101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A second target of cyclosporin A and FK506].
    Matsuda S; Koyasu S
    Tanpakushitsu Kakusan Koso; 2000 Aug; 45(11):1823-31. PubMed ID: 10936966
    [No Abstract]   [Full Text] [Related]  

  • 53. Cyclosporin A and FK506 reduce interleukin-5 mRNA abundance by inhibiting gene transcription.
    Rolfe FG; Valentine JE; Sewell WA
    Am J Respir Cell Mol Biol; 1997 Aug; 17(2):243-50. PubMed ID: 9271313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells.
    Sakuma S; Kato Y; Nishigaki F; Sasakawa T; Magari K; Miyata S; Ohkubo Y; Goto T
    Br J Pharmacol; 2000 Aug; 130(7):1655-63. PubMed ID: 10928971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tacrolimus (FK506) and cyclosporin A reduce macrophage recruitment to the rat brain injured at perinatal and early postnatal periods.
    Setkowicz Z; Caryk M; Szafraniec M; Zmudzińska A; Janeczko K
    Neurol Res; 2009 Dec; 31(10):1060-7. PubMed ID: 19138474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.
    Sigal NH; Dumont FJ
    Annu Rev Immunol; 1992; 10():519-60. PubMed ID: 1375473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mode of action of tacrolimus (FK506): molecular and cellular mechanisms.
    Thomson AW; Bonham CA; Zeevi A
    Ther Drug Monit; 1995 Dec; 17(6):584-91. PubMed ID: 8588225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclosporin A, but not FK506, prevents the downregulation of phosphorylated Akt after transient focal ischemia in the rat.
    Yoshimoto T; Uchino H; He QP; Li PA; Siesjö BK
    Brain Res; 2001 Apr; 899(1-2):148-58. PubMed ID: 11311876
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of the new immunosuppressive drug FK506 on the formation of secondary metabolites of cyclosporin A.
    Bauer S; Brockmöller J; Kewitz H; Roots I
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):540-2. PubMed ID: 1283385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
    Sawada S; Suzuki G; Kawase Y; Takaku F
    J Immunol; 1987 Sep; 139(6):1797-803. PubMed ID: 2442255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.